Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US biosimilars bill to grant 14.5 years of exclusivity
Under the Biosimilars bill introduced in the House on March 13, 2008, innovators would receive a minimum of 12 years of marketing exclusivity for a novel biological and
Under the Biosimilars bill introduced in the House on March 13, 2008, innovators would receive a minimum of 12 years of marketing exclusivity for a novel biological and
Prevelle Silk is a colorless hyaluronic acid (HA) gel with lidocaine that is injected into facial skin to reduce moderate to severe facial lines, folds, and wrinkles. The
All three conjugates involve SN-38, the active metabolite of irinotecan used in chemotherapeutic regimens for colorectal, lung, and pancreatic cancers. Due to its toxicity and poor solubility, SN-38
The case involved Edwards claiming patent infringement on four of Cook’s Zenith endovascular stent-grafts for use in treating abdominal aortic aneurysms and thoracic aortic aneurysms. Cynthia Kretz, general
The company anticipates that consideration for the acquisition will be in cash, with an initial payment of approximately RMB25.5 million. Tongjitang will make additional payments over the next
The study met its primary endpoints, demonstrating that the test successfully stratifies women with pelvic masses into high- and low-risk categories to determine whether the patient should be
Ambulatory infusion systems, like the CADD-Solis system, administer pain management medications, including narcotics, via a variety of delivery routes including intravenous and epidural. Jim Stitt, president of Smiths
Pharming understands that the Committee for Medicinal Products for Human Use (CHMP) does not have a specific concern on the safety and efficacy data submitted in the marketing
The carotid endarterectomy (CEA) study enrolled 50 patients and is designed to provide direct evaluation of VIA-2291’s effect on inflammation by analyzing plaque removed from the carotid arteries
The initial closing of the private placement consisted of the sale of 765 shares of series A convertible preferred stock for $1,000 per share. Each share of series